Skip to content

Nuvation Bio NUVB Shares (Basic)

Shares (Basic) at other companies

Pfizer logo
PfizerPFE
5.7B+0.3%
Nuvalent, Inc. logo
Nuvalent, Inc.NUVL
78.7M+9.9%
Immunome logo
ImmunomeIMNM
113.1M+42.5%
ArriVent BioPharma, Inc. logo
ArriVent BioPharma, Inc.AVBP
45.1M+32.9%
Arcus Biosciences logo
Arcus BiosciencesRCUS
125.4M+27.4%
Syndax Pharmaceuticals logo
Syndax PharmaceuticalsSNDX
88.3M+2.4%

Other financials

Income statement

See full
Revenue$83.2M+2,599%
Gross profit$9.8M+1,340%
Operating income$3.9M+107%
Net income$5.4M+110%
EPS (diluted)$0.01+106%

Balance sheet

See full
Cash & equivalents$125.4M+161%
Total debt$57.2M+401%
Total equity$319.6M-23.8%
Total assets$610.2M+23.9%

Cash flow

See full
Operating cash flow$5.1M+112%
CapEx$48.0K-33.3%
Free cash flow$5.0M+112%

Valuation

See full
Market cap$2.1B+150%
Enterprise value$2.03B+154%
P/S14.7×-62.0×

Profitability

See full
Gross margin54.3%+39.5pp
Operating margin-105%-52.0pp
Net margin-102.1%-50.6pp
FCF margin-93.5%-45.2pp

Returns & leverage

See full
Return on equity-39.5%-15.8pp
Debt / equity0.2×+0.2×
Current ratio7.4×-1.6×

Where this comes from

Reported directly by Nuvation Bio in its filing.

Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfSharesOutstandingBasic.

The official record: Nuvation Bio’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Nuvation Bio's shares (basic).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Nuvation Bio's shares (basic)?
Nuvation Bio (NUVB) reported shares (basic) of 347.3M in Q1 2026.
How has Nuvation Bio's shares (basic) changed year-over-year?
Nuvation Bio's shares (basic) increased by 2.6% year-over-year, from 338.6M to 347.3M.
What is the long-term trend for Nuvation Bio's shares (basic)?
Over 3 years (2022 to 2025), Nuvation Bio's shares (basic) has grown at a 16.4% compound annual growth rate (CAGR), from 865M to 1.4B.
What does shares (basic) mean?
The time-weighted average number of common shares outstanding during the period, used as the denominator for basic EPS calculations.